Crispr Therapeutics AG logo

Crispr Therapeutics AG (CRSP)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
56. 88
-1.3
-2.23%
$
4.67B Market Cap
- P/E Ratio
0% Div Yield
1,583,749 Volume
-2.71 Eps
$ 58.18
Previous Close
Day Range
56.01 58.73
Year Range
30.04 78.48
Want to track CRSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 64 days
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
10 Feb 2026 (In 2 months)
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
9 Feb 2026 (In 2 months)
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
5 Nov 2025
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
4 Nov 2025
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
29 Oct 2025
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
11 Aug 2025
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
30 May 2025
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
17 Feb 2025
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
4 Nov 2024
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
6 Aug 2024
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
30 May 2024
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
19 Feb 2024
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
30 Oct 2023
-
Cons. EPS
-
EPS
Crispr Therapeutics AG logo
CRSP Crispr Therapeutics AG
19 Oct 2016
-
Cons. EPS
-
EPS

CRSP Earnings Reports FAQ

What is the earnings per share (EPS) for CRSP?

The current EPS is -2.71.

What is the company's earnings growth rate?

Crispr Therapeutics AG has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-09, based on the CRSP's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Crispr Therapeutics AG are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for CRSP at this time, as Crispr Therapeutics AG has no recent EPS data to calculate it.